Literature DB >> 3308056

Gastric adenocarcinoma after gastric lymphoma.

B W Baron1, M A Bitter, J M Baron, D G Bostwick.   

Abstract

Three men and one woman developed intestinal-type moderately or poorly differentiated gastric adenocarcinoma 4 to 15 years after the diagnosis of gastric lymphoma. Treatment of the lymphomas had included partial gastrectomy and follow-up radiotherapy and/or chemotherapy. Review of the literature reveals an additional 12 patients who developed adenocarcinoma 3.5 to 34 years (median, 14.5 years) after diagnosis of gastric lymphoma. In the total series of 16 patients, only four were women, who tended to be younger (median age, 36.5 years) than the men (median, 48.5 years) when lymphoma was diagnosed. Patients with gastric lymphoma seem to have an increased incidence of gastric adenocarcinoma. Carcinoma after gastric lymphoma often arises in the distal stomach and appears to occur irrespective of the type of therapy for the lymphoma.

Entities:  

Mesh:

Year:  1987        PMID: 3308056     DOI: 10.1002/1097-0142(19871015)60:8<1876::aid-cncr2820600834>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Synchronous adenocarcinoma and primary malignant lymphoma of the stomach.

Authors:  A B Akosa; D M Clark; L Desa
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.

Authors:  Erhan Hamaloglu; Serdar Topaloglu; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 3.  Update on gastric lymphoma.

Authors:  C R Thomas
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

Review 4.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 5.  Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma.

Authors:  Daniel Rolf; Gabriele Reinartz; Stephan Rehn; Christopher Kittel; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.